You have 9 free searches left this month | to do more
Showing 1 - 25 of
7,720 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Active, not recruiting
  • Breast Cancer Female
  • Triple Negative and Androgen Receptor Positive
  • Caen, France
    Centre François Baclesse
2021-11-05
Nov 5, 2021
S
Terminated
  • Solid Tumor
  • Androgen Receptor Gene Overexpression
  • SEVI-D (Seviteronel in combination with dexamthasone)
  • Darlinghurst, New South Wales, Australia
    St Vincent's Hospital
2021-03-02
Mar 2, 2021
S
Recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    SKCCC at Johns Hopkins
2021-09-02
Sep 2, 2021
C
Active, not recruiting
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
2021-08-23
Aug 23, 2021
D
Completed
  • Prostate Cancer
  • Gainesville, Florida
  • +3 more
2021-09-27
Sep 27, 2021
U
Enrolling by invitation
  • Covid19
  • Androgen Receptor Gene Overexpression
  • COVID-19 Androgen Sensitivity Test (CoVAST)
  • Irvine, California
  • +1 more
2020-12-09
Dec 9, 2020
M
Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-12-08
Dec 8, 2020
N
Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • GnRH agonist/antagonist
  • +3 more
  • Los Angeles, California
  • +3 more
2021-04-30
Apr 30, 2021
U
Recruiting
  • Androgen Receptor Abnormal
  • +2 more
  • arterial reconstructive open surgery
  • Catanzaro, Italy
    University Magna Graecia of Catanzaro
2021-01-12
Jan 12, 2021
V
Active, not recruiting
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
2021-02-05
Feb 5, 2021
J
Active, not recruiting
  • Salivary Gland Neoplasms
  • Chuo-Ku, Japan
  • +6 more
2021-12-02
Dec 2, 2021
M
Recruiting
  • Androgen Receptor Positive
  • +15 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-09
Mar 9, 2021
U
Completed
  • Prostate Cancer
  • pTVG-AR
  • gm-csf
  • New Brunswick, New Jersey
  • +2 more
2021-02-02
Feb 2, 2021
D
Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +4 more
2021-01-11
Jan 11, 2021
T
Completed
  • Metastatic Castrate-resistant Prostate Cancer
  • Adenocarcinoma, Prostate
  • Birmingham, Alabama
  • +4 more
2021-03-29
Mar 29, 2021
M
Active, not recruiting
  • Advanced Epithelial Ovarian
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
2021-11-16
Nov 16, 2021
U
Not yet recruiting
  • Prostate Cancer Metastatic
  • Darolutamide 300 mg
  • +2 more
  • Villejuif, Ile De France, France
  • +1 more
2021-09-08
Sep 8, 2021
A
Recruiting
  • SARS-CoV 2
  • +5 more
  • CAG length <22
  • CAG length >=22
  • Madrid, Spain
    Hospital Universitario Ramon y Cajal
2021-07-20
Jul 20, 2021
U
Recruiting
  • Breast Cancer
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
2021-06-22
Jun 22, 2021
R
Recruiting
  • Stage II Prostate Adenocarcinoma
  • Stage III Prostate Adenocarcinoma
  • Abiraterone Acetate
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
2021-04-02
Apr 2, 2021
J
Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2021-06-29
Jun 29, 2021
V
Active, not recruiting
  • Estrogen Receptor Negative
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
2021-05-04
May 4, 2021